Effects of the Application of a Reflex Locomotion Program in the Neurological Hand

April 5, 2020 updated by: Luis Perales Lopez, NUMEN Foundation

Effects of the Application of a Reflex Locomotion Program on Sitting in the Neurological Hand of the Chronic Adult Patient

The recovery of the function of the hand is one of the most important aspects for patients who have suffered the consequences of neurological damage. Currently there are numerous therapeutic procedures aimed at rehabilitation that have scientific evidence such as restrictive therapy. However, dysfunction of the upper limb has an impact on the whole body that is not always taken into consideration.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The intervention of the stimulation of the reflex locomotion is carried out in this study in a sitting position in a conventional chair, an unorthodox posture in the usual treatment of Vojta therapy.

Description of the sitting posture: the back in axial extension with the shoulders located in front of the hips.

The elbows must be supported with the medial epicondyl in contact on a table, whose height is at the level of the end of the patient's sternum.

The forearms are placed prone with the palms facing the surface. In this position we place a rubber sphere 3 centimeters in diameter under the pisiform of one of the patient's wrists.

The reflex stimulation is performed by the passive pressure exerted by the weight of the wrist (pisiform) on the rubber sphere. Simultaneously the patient has to exert a slight pressure with the heel towards the ground with his foot. This foot will be the opposite of the wrist that has the sphere under the pisiform.

It is a cross-stimulation, that is, pisiform in one hand together with the load in the heel of the opposite side.

Alternating each diagonal 4 times, 5 minutes each. Total session 20 minutes, 2 times per day, every day according to degree of affectation

The duration of the study will depend on the degree of involvement: mild 2 weeks, moderate 3 months.

Study Type

Interventional

Enrollment (Actual)

12

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • España
      • Madrid, España, Spain, 28027
        • NUMEN Foundation

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Sequelae in the upper limb after neurological damage.
  • Understanding and oral expression preserved.
  • More than a year after the episode.
  • Possibility of walking

Exclusion Criteria:

  • Aphasia.
  • Concomitant diseases: Diabetes and arthritis of the hand.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental
Adult patients with chronic sequelae in the upper limb after neurological damage

The intervention of the stimulation of the reflex locomotion is carried out in this study in a sitting position in a conventional chair, an unorthodox posture in the usual treatment of Vojta therapy.

The reflex stimulation is performed by the passive pressure exerted by the weight of the wrist (pisiform) on the rubber sphere. Simultaneously the patient has to exert a slight pressure with the heel towards the ground with his foot. This foot will be the opposite of the wrist that has the sphere under the pisiform.

Alternating each diagonal 4 times, 5 minutes each. Total session 20 minutes, 2 times x day, every day according to degree of affectation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
kinesiological test of the upper limb
Time Frame: 2 weeks for mild grade and 3 months for moderate degree
Shoulder: flexion and maximum abduction. Forearm: Supination / pronation. Wrist: maximum dorsal flexion. Hand: finger extension
2 weeks for mild grade and 3 months for moderate degree
The Box and Block Test
Time Frame: 2 weeks for mild grade and 3 months for moderate degree.
The Box and Block Test is a functional outcome measure that is commonly used across multiple clinical populations due to its benefits of ease and speed of implementation; reliable, objective measurement; and repetition of motion.
2 weeks for mild grade and 3 months for moderate degree.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Luis Perales Lopez, Doctor, NUMEN Foundation

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 29, 2019

Primary Completion (Actual)

July 30, 2019

Study Completion (Actual)

September 25, 2019

Study Registration Dates

First Submitted

March 23, 2019

First Submitted That Met QC Criteria

March 25, 2019

First Posted (Actual)

March 26, 2019

Study Record Updates

Last Update Posted (Actual)

April 7, 2020

Last Update Submitted That Met QC Criteria

April 5, 2020

Last Verified

April 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • NUMEN1

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Neurological Disorder

Clinical Trials on Reflex locomoction therapy

Subscribe